| Serial Number | 98860857 |
| Word Mark | MERIBEL PHARMA SOLUTIONS |
| Filing Date | Tuesday, November 19, 2024 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Thursday, May 15, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Custom manufacture of pharmaceuticals; custom manufacture of medicines and vaccines; custom manufacture of products relating to biotechnology; custom manufacture of pharmaceuticals and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; custom manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products; contract manufacturing services; pharmaceutical contract manufacturing services; biotechnology contract manufacturing services; contract manufacture of pharmaceuticals and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; contract manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products |
| Goods and Services | Pharmaceutical preparations; biological preparations; pharmaceutical substances and preparations; vaccines; vaccine manufacturing preparations; reagents for medical use; diagnostic preparations; diagnostic reagents for medical use; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use; immunotherapeutic drugs; therapeutic and prophylactic pharmaceutical products; gene therapy products; pharmaceuticals in the form of nanoparticles for delivery; pharmaceutical substances and preparations, nanoparticles, viral vectors, retroviral vectors, lentiviral vectors and non-viral vectors for the delivery of genes to cells, all for medical purposes; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders |
| Goods and Services | Scientific and technological services and research and design relating thereto; industrial analysis services; laboratory services; research and development services; pharmaceutical research and development services; research and development in the biotechnology field; biological research, clinical research and medical research; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; conducting clinical trials; pharmaceutical testing and clinical trials; pharmaceutical drug developments services; research and development of pharmaceutical preparations; research and development of vaccines and medicines; research and development of gene-based medicines; research and laboratory analytic and diagnostic services; design of manufacturing facilities; manufacturing development services; quality control and validation services; genetic engineering laboratories and biochemistry laboratories; product development consultancy in the field of pharmaceuticals; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; product development consultancy in the field of pharmaceuticals and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; product development consultancy in the field of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products; provision of information relating to scientific research; provision of scientific information; research and scientific analysis relating to drug discovery and development for others; scientific advisory services; scientific consultancy; pharmaceutical consultancy; management of scientific research projects; management of pharmaceutical projects; issuing of scientific information; provision of information and consultancy in relation to the aforesaid services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 19, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 19, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 19, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BW CDMO Holdings UK Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London SW1H0DB GB |
| Event Date | Event Description |
| Tuesday, November 19, 2024 | NEW APPLICATION ENTERED |
| Saturday, April 26, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 15, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, May 15, 2025 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, July 2, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, July 15, 2025 | ASSIGNED TO LIE |
| Thursday, May 15, 2025 | SUSPENSION LETTER WRITTEN |
| Tuesday, May 13, 2025 | ASSIGNED TO EXAMINER |